Pelthos Therapeutics Inc.
PTHS
$23.42
-$1.13-4.60%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -855.87% | -600.88% | -444.56% | -134.22% | 7.73% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 25.10% | 99.61% | -62.56% | -37.45% | -53.61% |
| Total Other Non-Cash Items | 2,694.61% | 1,218.05% | 1,583.85% | 52.73% | -62.18% |
| Change in Net Operating Assets | -214.06% | -927.84% | -17,443.14% | -1,594.51% | 846.01% |
| Cash from Operations | -2,095.50% | -691.58% | -290.02% | -210.43% | 65.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 11,196.18% | 5,965.90% | 3,368.47% | -37.69% | -121.75% |
| Total Debt Repaid | -1,329,400.00% | -1,329,400.00% | -293.02% | -293.02% | 99.91% |
| Issuance of Common Stock | 148.19% | 148.19% | -96.60% | -97.30% | -98.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 144.58% | 99.45% |
| Cash from Financing | 17,339.62% | 9,052.78% | 630.17% | 305.95% | -105.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,144.52% | 982.03% | 4,099.11% | 954.54% | -200.97% |